Human mesenchymal stromal cells ameliorate cisplatin-induced acute and chronic kidney injury via TSG-6
Stem Cells · 2024
DOI: 10.1093/stmcls/sxae037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells, 2024. Verfasst von Ming Tang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Urinary Nephropathy Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400065, People's Republic of China. Hauptthemen laut MEDLINE: Cisplatin, Mesenchymal Stem Cells, Acute Kidney Injury, Cell Adhesion Molecules. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Chongqing, Chongqing Postdoctoral Science Special Foundation.
Abstract (Originalsprache)
Cisplatin is widely used in tumor chemotherapy, but nephrotoxicity is an unavoidable side effect of cisplatin. Several studies have demonstrated that mesenchymal stromal cells (MSCs) ameliorate cisplatin-induced kidney injury, but the underlying mechanisms are unknown. In this study, the cisplatin-induced kidney injury mouse model was established by subjecting a single intraperitoneal injection with cisplatin. One hour before cisplatin injection, the mice received human bone marrow MSCs (hBM-MSCs) with or without siRNA-transfection, recombinant human tumor necrosis factor-α-stimulated gene/protein 6 (rhTSG-6), or PBS through the tail vein. In addition, cisplatin-stimulated HK-2 cells were treated with hBM-MSCs or rhTSG-6. Human BM-MSCs treatment remarkably ameliorated cisplatin-induced acute and chronic kidney injury, as evidenced by significant reductions in serum creatinine (Scr), blood urea nitrogen, tubular injury, collagen deposition, α-smooth muscle actin accumulation, as well as inflammatory responses, and by remarkable increased anti-inflammatory factor expression and Treg cells infiltration in renal tissues. Furthermore, we found that only a few hBM-MSCs engrafted into damaged kidney and that the level of human TSG-6 in the serum of mice increased significantly following hBM-MSCs administration. Moreover, hBM-MSCs significantly increased the viability of damaged HK-2 cells and decreased the levels of inflammatory cytokines in the culture supernatant. However, the knockdown of the TSG-6 gene in hBM-MSCs significantly attenuated their beneficial effects in vivo and in vitro. On the contrary, treated with rhTSG-6 achieved similar beneficial effects of hBM-MSCs. Our results indicate that systemic administration of hBM-MSCs alleviates cisplatin-induced acute and chronic kidney injury in part by paracrine TSG-6 secretion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Urinary Nephropathy Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400065, People's Republic of China.
- Department of Immunology, Army Medical University (Third Military Medical University), Chongqing 400038, People's Republic of China.
ORCID-Profile: Ming Tang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Chongqing
- Chongqing Postdoctoral Science Special Foundation
Zitieren
APA
Tang, M., Shen, L., Tang, M., Liu, L., Rao, Z., Wang, Z., Wang, Y., Yin, S., Li, S., Xu, G., & Zhang, K. (2024). Human mesenchymal stromal cells ameliorate cisplatin-induced acute and chronic kidney injury via TSG-6. Stem Cells. https://doi.org/10.1093/stmcls/sxae037
Vancouver
Tang M, Shen L, Tang M, Liu L, Rao Z, Wang Z, et al. Human mesenchymal stromal cells ameliorate cisplatin-induced acute and chronic kidney injury via TSG-6. Stem Cells. 2024. doi:10.1093/stmcls/sxae037
BibTeX
@article{Tang2024,
author = {Tang, Ming and Shen, Linguo and Tang, Maozhi and Liu, Ling and Rao, Zhengsheng and Wang, Zhilin and Wang, Yadi and Yin, Supei and Li, Shujing and Xu, Guilian and Zhang, Keqin},
title = {Human mesenchymal stromal cells ameliorate cisplatin-induced acute and chronic kidney injury via TSG-6},
journal = {Stem Cells},
year = {2024},
doi = {10.1093/stmcls/sxae037}
}
EUVIMED